Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb

Arch Dermatol. 2010 Dec;146(12):1438-9. doi: 10.1001/archdermatol.2010.367.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Benzenesulfonates / administration & dosage
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Squamous Cell / chemically induced*
  • Carcinoma, Squamous Cell / diagnosis
  • Drug Administration Routes
  • Follow-Up Studies
  • Humans
  • Leg
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Neoplasm Metastasis
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / administration & dosage
  • Pyridines / adverse effects*
  • Receptors, Vascular Endothelial Growth Factor
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / diagnosis
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • Receptors, Vascular Endothelial Growth Factor